Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa

Abstract Background Despite its low cure rates and possible resistance, praziquantel (PZQ) is the only drug available for schistosomiasis treatment. Hence, monitoring its efficacy is crucial. This study assessed the efficacy of PZQ, determined re-infection and incidence rates of Schistosoma haematob...

Full description

Bibliographic Details
Main Authors: Muhubiri Kabuyaya, Moses John Chimbari, Tawanda Manyangadze, Samson Mukaratirwa
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Infectious Diseases of Poverty
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40249-017-0293-3